Background: Patients with myocardial infarction are faced to multi stressors in which cause to increase their anxiety. This study with the goal of determination of the effect of Durosia Anethifolia (Barilax) on anxiety after myocardial infarction was accomplished.

Materials and Methods:This is a clinical trial which was done on 90 patients with MI. All people were selected by simple method at first and then they randomly allocated into two intervention and control groups. After 24 hours, perl of Barilax 1oo mg twice per day were prescribed for intervention group, and the same dosage of placebo were given to control group. Anxity rate 24 and 96 hours after MI by state Trait Anxiety Inventory (STAI) were measured. All data with X2 and paired T test were analysed.

Results: The mean age of patients in intervention group was 60.68 and 61.46 in control group. In intervention group 51% male and 49% were female and in control group 71% were male and 29% were female. Before intervention, the mean of anxiety rate in intervention group was 46.91 and in control group was 42.24 with no significant difference. After intervention, the mean of anxiety rate in intervention group was 33.35 and in control group was 36.48 with significant difference (p=0.012).

Conclusion: Oral consumption of Durosia Anethifolia (Barilax) on anxiety rate after myocardial infarction was effective. So description of this drug as an effective drug on controling of anxiety after myocardial infarction is recommended.